New drug may be the breath of life in intensive care

June 7, 2011

A new drug to treat potentially fatal lung injuries caused by ventilators in hospital intensive care units is being developed by Flinders University researchers.

Ms Alison Elder, a PhD candidate in the Department of , and her colleagues have trialled feG, a new anti-inflammatory drug that is successful in treating and , in models of lung injury in rats.

They found the drug may be able to both prevent and effectively treat ventilator-induced lung injury.

“Ventilators are essential to keep people breathing in intensive care, but can also cause deadly lung damage by forcefully stretching the delicate tissues of the lung,” Ms Elder said.

“By significantly reducing lung damage and improving respiratory function this drug could reduce patient mortality in the ,” she said.

Stretching of the lung tissue triggers our immune system to release chemicals that cause inflammation. This can result in further tissue damage, impaired oxygen exchange and fluid accumulation in the lung, leading to death.

“The drug works in three ways: it decreases the infiltration of the inflammatory cells into the lung; it decreases their activation; and it encourages resolution of the injury within the lung,” Ms. Elder said.

Mortality rates for patients with acute increase from 24 per cent for patients 15-19 years old up to 60 per cent for patients 85 years and older, and it is also a significant financial burden for the health system.

The drug, which is based on a natural substance found in the salivary glands of rats, is currently being tested for treating asthma in Phase 1 trials by collaborators in Canada.

“Since patient safety testing has already begun in the asthma study, we are hoping to be in a position to start clinical trials here in Adelaide within the next few years.”

Explore further: Inhaling hydrogen may help reduce lung damage in critically ill patients

Related Stories

Recommended for you

Genes linked with malaria's virulence shared by apes, humans

October 12, 2015

The malaria parasite molecules associated with severe disease and death—those that allow the parasite to escape recognition by the immune system—have been shown to share key gene segments with chimp and gorilla malaria ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.